Clinical trials - Press Releases

Date	Title	Company
13-Apr-2021	First patient dosed in phase 3 XTEND-Kids study with efanesoctocog alfa in children with haemophilia A	Swedish Orphan Biovitrum AB (publ) (Sobi™)
13-Apr-2021	iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its Anti-TIGIT Antibody, EOS-448, at the AACR Annual Meeting 2021	iTeos Therapeutics
13-Apr-2021	Lundbeck and Otsuka announce decision to continue phase III clinical trial evaluating brexpiprazole for treatment of agitation in patients with Alzheimer’s-type dementia	Lundbeck and Otsuka
13-Apr-2021	CloudLIMS Adds a HIPAA-Compliant Patient Portal to its COVID-19 LIMS for Diagnostic Labs to Offer a Seamless Experience to Testees	CloudLIMS
13-Apr-2021	Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 Serene Study Evaluating Contraceptive Efficacy of Once-Daily Relugolix Combination Tablet	Pfizer
12-Apr-2021	Update on the DARE-19 Phase III trial for Farxiga in COVID-19	AstraZeneca
12-Apr-2021	Lilly Presents New Data on Retevmo® (selpercatinib) in Advanced RET Fusion-Positive Gastrointestinal and Other Cancers at 2021 American Association for Cancer Research (AACR) Annual Meeting	Lilly
12-Apr-2021	Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81%	Roche
09-Apr-2021	Occupational Toxicology and Placing Worker Safety at the Forefront to be discussed at HPAPi Conference	SMi Group
09-Apr-2021	Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients	Lilly
09-Apr-2021	Interim late-breaking clinical data validate not-alpha profile of THOR-707 (SAR444245), Sanofi’s novel investigational IL-2	Sanofi
09-Apr-2021	Merck’s KEYTRUDA® (pembrolizumab) Demonstrated Superior Disease-Free Survival (DFS) Compared With Placebo as Adjuvant Therapy in Patients With Renal Cell Carcinoma (RCC) Following Surgery	Merck
08-Apr-2021	Exclusive Speaker Interview with Achim Kless, Pain Genetics Lead from Eli Lilly & Company ahead of Pain Therapeutics	SMi Group
08-Apr-2021	Positive results from the sutimlimab pivotal trial for people with cold agglutinin disease published in New England Journal of Medicine	Sanofi
07-Apr-2021	FDA Keynote Speakers at SMi's 4th Annual Pharmaceutical Microbiology East Coast Virtual Conference in 3 weeks	SMi Group
06-Apr-2021	Antibody Production Market Report 2021-2031 : Newly Published By Visiongain	Visiongain Ltd.
06-Apr-2021	Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials	Parexel
05-Apr-2021	Allergy Treatment Market Worth US$ 35,812.33 Mn by 2028 and to grow at a CAGR of 6.9%	theinsightpartners
05-Apr-2021	Pre-Clinical Research Development for Current Regulatory Requirements	Clariwell Global Services
05-Apr-2021	How site management organization (SMO)Work?	Clariwell Global Services LLP